2021-01-11,Nemaura Medical To Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
2020-12-17,"Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT Non-Invasive, Daily-Wear Adhesive Glucose Monitor"
2020-12-11,Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference
2020-11-17,Nemaura Medical Launches BEATdiabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website
2020-11-16,Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update
2020-10-22,Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020
2020-09-21,Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products
2020-09-18,Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer
2020-09-03,Nemaura Medical to Provide US proBEAT Launch Update at The LD 500 Virtual Conference
2020-08-31,(LD Micro) 360 Companies Set to Present this Week
2020-08-25,Nemaura Medical to Present at The LD 500 Virtual Conference
2020-08-19,Nemaura Medical Issues Presentation Pertaining to the use of Continuous Glucose Monitoring in COVID-19 Patients
2020-08-17,"Nemaura Medical Reports Results and Provides Business Update for the First Quarter Ended June 30, 2020"
2020-08-06,LD Micro: Announces Preliminary List of Presenters for the LD-500
2020-07-28,Nemaura Announces Correction and Pricing of Public Offering
2020-07-27,Nemaura Announces Proposed Underwritten Public Offering
2020-07-27,Here's What Nemaura Medical Inc.'s (NASDAQ:NMRD) Shareholder Ownership Structure Looks Like
2020-07-27,"Nemaura Enters into Letter of Intent to Acquire Healthimation, LLC to Augment proBEAT Launch in the U.S."
2020-07-23,Nemaura Medical to Integrate Activity Data From Third Party Wearable Devices to Its proBEAT App
2020-07-14,Nemaura Medical Evaluates New Applications for Continuous Lactate Monitoring Using its BEAT Platform
2020-07-07,Nemaura Medical Submits PMA Application for sugarBEAT® to U.S. FDA
2020-06-30,"Nemaura Medical Reports Results and Provides Business Update for the Fiscal Year Ended March 31, 2020"
2020-06-26,Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
2020-06-23,"Nemaura Medical CEO to Participate in Investor Webinar and Q&A Session on July 7, 2020"
2020-06-16,Nemaura Participated as Guest Speaker at DiabetesMine D-Data ExChange 2020
2020-06-10,Nemaura Medical to Present at Credit Suisse 2020 Virtual Diabetes Sessions
2020-06-09,Nemaura Medical Set to Join the Russell 2000® Index and Russell 3000® Index
2020-05-20,Nemaura Medical 2020 Stock Incentive Plan Approved at Annual General Meeting
2020-05-11,Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device
2020-05-05,Nemaura Medical Announces Interview with CEO to Air on May 11
2020-04-21,Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy
2020-04-01,Nemaura Plans To Launch Body-Worn Continuous Temperature Monitor (CTM) to Track Fever Caused by Viral Infections such as COVID-19
2020-03-30,Nemaura Medical: The Potential proBEAT Launch Adds Some Steam
2020-03-30,"Nemaura to Launch New Digital Brand proBEAT in the USA, Targeting a Market of Over 100 Million Potential Users With Its Prescription-Free Consumer Wellness Glucose Monitoring Device and Digital Healthcare Subscription Service"
2020-03-20,Nemaura Medical: A Diabetes-Oriented Med-Tech Play
2020-03-20,Nemaura Medical Launches Non-Invasive Glucose Monitor in the US
2020-03-18,Nemaura To Prepare for Launch of sugarBEAT® CGM In the U.S. Following FDA Feedback
2020-03-10,Nemaura Medical Enters Into Multiple Verbal Non-Binding Agreements for its sugarBEAT® Platform
2020-03-03,Nemaura Medical Launches sugarBEAT® App on Play Store Ahead of its Planned Commercial Launch of BEAT®diabetes Subscription Service
2020-02-25,Nemaura Medical Plans Head-to-head Study with Major Glucose Monitoring System
2020-02-11,"Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019"
2019-12-20,Nemaura Provides 2019 Year-End Corporate Update
2019-12-17,Nemaura Medical and Changing Health announce Partnership to provide award-winning Diabetes Behavioral Change services
2019-12-05,Nemaura Medical announces expansion of SugarBEAT® offering  with BEAT® Diabetes digital subscription services
2019-12-04,Nemaura Medical Announces 1 for 10 Reverse Split Intended to Attract a Wider Universe of Institutional Investors
2019-11-12,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat"
2019-11-11,"Nemaura Medical Reports Results and Provides Business Update for the Second Quarter Ended September 30, 2019"
2019-10-03,Nemaura Medical Provides Update Regarding Commercial Launch of SugarBEAT® and First Patient User Experiences as Presented at EASD Symposia 2019 in Barcelona
2019-09-20,Is Nemaura Medical (NASDAQ:NMRD) In A Good Position To Invest In Growth?
2019-09-12,"Nemaura Medical to Hold a Symposia at EASD in Barcelona on Thursday September 19, 2019"
2019-08-09,"Nemaura Medical Reports Quarterly Results for First Quarter Ended June 30, 2019"
2019-08-07,Nemaura Medical Announces First Shipments of SugarBEAT® Devices to Diabetic and Pre-Diabetic Patients as Part of its First Phase of Launch
2019-08-01,Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors
2019-07-18,Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
2019-07-10,Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
2019-06-17,Nemaura Provides Fiscal 2019 Year-End Business Update
2019-06-14,Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
2019-05-29,Nemaura Announces CE Mark Approval of SugarBEAT®
2019-05-27,The Nemaura Medical (NASDAQ:NMRD) Share Price Is Down 63% So Some Shareholders Are Wishing They Sold
2019-05-02,Nemaura Announces Open-Source Software for its Continuous Glucose Monitor SugarBEAT®
2019-04-23,Nemaura Announces Successful Completion of Summative Human Factors Usability Study for SugarBEAT®
2019-04-16,Nemaura Announces Addition of New Predictive Alert Functionality to SugarBEAT®
2019-03-28,Nemaura CEO Provides Update to Shareholders
2019-03-12,Nemaura Medical Announces Exclusive License and Supply Agreement for SugarBEAT® in the GCC Region
2019-02-12,Nemaura Reports Third Quarter 2018 Financial Results
2019-02-11,Nemaura Announces Dr. Fred Schaebsdau to Lead Strategy and Business Development
2019-02-07,Nemaura Medical Announces Grant of U.S. Patent for SugarBEAT® Glucose Sensing Algorithm
2019-01-17,Nemaura Medical Announces Improvement to SugarBEAT® Continuous Glucose Monitor
2018-12-21,Nemaura Announces Completion of Key Stages of Technical File Review for SugarBEAT® CE Mark Approval
2018-12-20,"Dawson James Securities Announces Closing of $2.0 Million Offering for Nemaura Medical, Inc."
2018-12-19,Nemaura to Host Investor Webinar on December 21 to Provide Update on Recent Developments
2018-12-18,Why Micro Cap Nemaura Medical Crashed 39.5% Today
2018-12-18,Nemaura Publishes Positive Data from SugarBEAT® FDA Clinical Trial
2018-12-18,Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering
2018-12-17,Nemaura Medical Announces Proposed Public Offering
2018-12-12,"Nemaura to Present SugarBEAT® Clinical Performance Poster at ATTD, Berlin"
2018-12-04,Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission
2018-11-20,Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar
2018-11-14,Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
2018-11-12,Nemaura Medical to Present at the Stifel 2018 Healthcare Conference
2018-11-08,Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results
2018-11-07,Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®
2018-10-22,Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments
2018-09-25,Nemaura Reports Positive Zero Finger-Stick Calibration Data for SugarBEAT® Continuous Glucose Monitor
2018-09-18,Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar
2018-09-13,Why Micro Cap Nemaura Medical Skyrocketed 32% Yesterday
2018-09-12,Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial
2018-08-09,Nemaura Medical Inc. Reports First Quarter 2018 Financial Results
2018-07-31,"Nemaura Initiates US FDA Studies, and Reports Positive Interim Data from Home-Use Portion of Study"
2018-07-17,Nemaura Places SugarBEAT® Manufacturer Order for UK Commercial Launch
2018-06-13,Nemaura Medical Inc. Reports Full Year Financial Results
2018-05-30,Nemaura Medical Signs Joint Collaboration Agreement for European Commercialization
2018-05-15,Nemaura Medical to Present at the UBS Global Healthcare Conference
2018-04-09,Nemaura Medical Appoints Bashir Timol Chief Business Officer
2018-03-28,Nemaura Medical Appoints The Ruth Group as Investor and Public Relations Counsel
2018-03-06,Nemaura Medical to Ring the Nasdaq Closing Bell
2018-03-05,CORRECTING and REPLACING -- Nemaura Medical Inc. (Nasdaq: NMRD) to Ring The Nasdaq Stock Market Closing Bell
2018-03-05,Nemaura Medical Inc. (Nasdaq: NMRD) to Ring The Nasdaq Stock Market Closing Bell
2018-03-01,Nemaura Announces Expansion of Manufacturing Capabilities for SugarBEAT® Commercial Launch
2018-02-09,Nemaura Medical Inc. Reports Third Quarter 2017 Financial Results
